Basket

  Untick selected:   0

  1.  

    TitleLong-term angiotensin II AT(1) receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPAR-gamma
    Author Zorad Štefan SAVEXEND - Ústav experimentálnej endokrinológie SAV
    Co-authors Dou J. T.
    Benický Július SAVEXEND - Ústav experimentálnej endokrinológie SAV
    Hutanu D.
    Kršková Katarína SAVEXEND - Ústav experimentálnej endokrinológie SAV
    Zhou Jian-Ming
    Saavedra J. M.
    Source document European Journal of Pharmacology : an international journal. Vol. 552, no. 1-3, (2006), p. 112-122
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2006
    DOI 10.1016/j.ejphar.2006.08.062
    article

    article

  2.  

    TitlePredicted inhibitors of aldose reductase based on 2-(3-oxotriazinoindole-5-yl)acetic acid: their synthesis and biological activity
    Author Kováčiková Lucia 1983- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV
    Co-authors Hlaváč Matúš 1991-
    Addová Gabriela 1974-
    Boháč Andrej 1964-
    Štefek Milan 1950-2023 SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV
    Action VEGA č. 2/0041/15. Deriváty kyseliny 1-indoloctovej ako inhibítory aldózareduktázy: dizajn, syntéza a biologická aktivita : 01.01.2015 - 31.12.2017
    Source document Book of abstracts of the Conference on the 65th Anniversary of Faculty of Pharmacy, Comenius University in Bratislava - 46th EuroCongress on Drug Synthesis and Analysis. P. 177. - Bratislava : Comenius University, 2017 ; Conference on the 65th Anniversary of Faculty of Pharmacy, Comenius University in Bratislava ; EuroCongress on Drug Synthesis and Analysis
    CategoryAFH - Abstracts of papers from domestic conferences
    Year2017
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all